HARVARD BIOSCIENCE, INC. Selling and Marketing Expense
HARVARD BIOSCIENCE, INC. (HBIO) reported Selling and Marketing Expense of $5.40 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingAndMarketingExpense · last filed 2026-08-11
- HARVARD BIOSCIENCE, INC. selling and marketing expense for the quarter ending 2026-06-30 was $5.40M, a 18.97% increase year-over-year.
- HARVARD BIOSCIENCE, INC. selling and marketing expense for the quarter ending 2026-03-31 was $5.33M, a 7.32% increase year-over-year.
- HARVARD BIOSCIENCE, INC. selling and marketing expense for the quarter ending 2025-12-31 was $5.09M, a 5.60% decline year-over-year.
- HARVARD BIOSCIENCE, INC. selling and marketing expense for the quarter ending 2025-09-30 was $4.61M, a 16.40% decline year-over-year.
- HARVARD BIOSCIENCE, INC. selling and marketing expense for fiscal 2025 was $19.22M, a 13.49% decline from fiscal 2024.
- HARVARD BIOSCIENCE, INC. selling and marketing expense for fiscal 2024 was $22.21M, a 7.68% decline from fiscal 2023.
- HARVARD BIOSCIENCE, INC. selling and marketing expense for fiscal 2023 was $24.06M, a 3.92% decline from fiscal 2022.
- HARVARD BIOSCIENCE, INC. selling and marketing expense for fiscal 2022 was $25.04M, a 1.62% increase from fiscal 2021.
| Period end | Selling and Marketing Expense 3 month | Selling and Marketing Expense 3 month as first filed | Selling and Marketing Expense 6 month | Selling and Marketing Expense 6 month as first filed | Selling and Marketing Expense 9 month | Selling and Marketing Expense 9 month as first filed | Selling and Marketing Expense 12 month | Selling and Marketing Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $5.40M 10-Q · filed 2026-08-11 | $10.73M 10-Q · filed 2026-08-11 | $15.83M derived: sum of 3 quarters · filed 2026-08-11 | $20.44M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2026-03-31 | $5.33M 10-Q · filed 2026-05-12 | $10.43M derived: sum of 2 quarters · filed 2026-05-12 | $15.04M derived: sum of 3 quarters · filed 2026-05-12 | $19.58M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-12-31 | $5.09M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $9.71M derived: sum of 2 quarters · filed 2026-03-13 | $14.24M derived: sum of 3 quarters · filed 2026-08-11 | $19.22M 10-K · filed 2026-03-13 | ||||
| 2025-09-30 | $4.61M 10-Q · filed 2025-11-06 | $9.15M derived: sum of 2 quarters · filed 2026-08-11 | $14.12M 10-Q · filed 2025-11-06 | $19.52M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-06-30 | $4.54M 10-Q · filed 2026-08-11 | $9.51M 10-Q · filed 2026-08-11 | $14.90M derived: sum of 3 quarters · filed 2026-08-11 | $20.42M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-03-31 | $4.97M 10-Q · filed 2026-05-12 | $10.37M derived: sum of 2 quarters · filed 2026-05-12 | $15.88M derived: sum of 3 quarters · filed 2026-05-12 | $21.28M derived: sum of 4 quarters · filed 2026-05-12 | ||||
| 2024-12-31 | $5.39M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $10.91M derived: sum of 2 quarters · filed 2026-03-13 | $16.31M derived: sum of 3 quarters · filed 2026-03-13 | $22.21M 10-K · filed 2026-03-13 | ||||
| 2024-09-30 | $5.52M 10-Q · filed 2025-11-06 | $10.91M derived: sum of 2 quarters · filed 2025-11-06 | $16.82M 10-Q · filed 2025-11-06 | $22.99M derived: sum of 4 quarters · filed 2025-11-06 | ||||
| 2024-06-30 | $5.39M 10-Q · filed 2025-08-11 | $11.30M 10-Q · filed 2025-08-11 | $17.47M derived: sum of 3 quarters · filed 2025-08-11 | $23.20M derived: sum of 4 quarters · filed 2025-08-11 | ||||
| 2024-03-31 | $5.90M 10-Q · filed 2025-05-12 | $12.08M derived: sum of 2 quarters · filed 2025-05-12 | $17.81M derived: sum of 3 quarters · filed 2025-05-12 | $23.99M derived: sum of 4 quarters · filed 2025-05-12 | ||||
| 2023-12-31 | $6.17M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14 | $11.90M derived: sum of 2 quarters · filed 2025-03-14 | $18.08M derived: sum of 3 quarters · filed 2025-03-14 | $24.06M 10-K · filed 2025-03-14 | $24.11M 10-K · filed 2024-03-07 | |||
| 2023-09-30 | $5.73M 10-Q · filed 2024-11-08 | $11.91M derived: sum of 2 quarters · filed 2024-11-08 | $17.89M 10-Q · filed 2024-11-08 | $23.84M derived: sum of 4 quarters · filed 2024-11-08 | ||||
| 2023-06-30 | $6.18M 10-Q · filed 2024-08-08 | $12.16M 10-Q · filed 2024-08-08 | $18.10M derived: sum of 3 quarters · filed 2024-08-08 | $23.92M derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | $5.98M 10-Q · filed 2024-05-07 | $11.93M derived: sum of 2 quarters · filed 2024-05-07 | $17.75M derived: sum of 3 quarters · filed 2024-05-07 | $24.33M derived: sum of 4 quarters · filed 2024-05-07 | ||||
| 2022-12-31 | $5.95M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $11.77M derived: sum of 2 quarters · filed 2024-03-07 | $18.35M derived: sum of 3 quarters · filed 2024-03-07 | $25.04M 10-K · filed 2024-03-07 | ||||
| 2022-09-30 | $5.82M 10-Q · filed 2023-11-07 | $12.41M derived: sum of 2 quarters · filed 2023-11-07 | $19.09M 10-Q · filed 2023-11-07 | $26.44M derived: sum of 4 quarters · filed 2023-11-07 | ||||
| 2022-06-30 | $6.59M 10-Q · filed 2023-08-08 | $13.27M 10-Q · filed 2023-08-08 | $20.62M derived: sum of 3 quarters · filed 2023-08-08 | $26.80M derived: sum of 4 quarters · filed 2023-08-08 | ||||
| 2022-03-31 | $6.69M 10-Q · filed 2023-04-26 | $14.03M derived: sum of 2 quarters · filed 2023-04-26 | $20.21M derived: sum of 3 quarters · filed 2023-04-26 | $25.94M derived: sum of 4 quarters · filed 2023-04-26 | ||||
| 2021-12-31 | $7.34M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $13.53M derived: sum of 2 quarters · filed 2023-03-09 | $19.26M derived: sum of 3 quarters · filed 2023-03-09 | $24.64M 10-K · filed 2023-03-09 | ||||
| 2021-09-30 | $6.18M 10-Q · filed 2022-11-09 | $11.91M derived: sum of 2 quarters · filed 2022-11-09 | $17.30M 10-Q · filed 2022-11-09 | $22.77M derived: sum of 4 quarters · filed 2022-11-09 | ||||
| 2021-06-30 | $5.73M 10-Q · filed 2022-08-04 | $11.12M 10-Q · filed 2022-08-04 | $16.59M derived: sum of 3 quarters · filed 2022-08-04 | $21.17M derived: sum of 4 quarters · filed 2022-08-04 | ||||
| 2021-03-31 | $5.39M 10-Q · filed 2022-05-04 | $10.86M derived: sum of 2 quarters · filed 2022-05-04 | $15.44M derived: sum of 3 quarters · filed 2022-05-04 | $19.72M derived: sum of 4 quarters · filed 2022-05-04 | ||||
| 2020-12-31 | $5.47M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $10.06M derived: sum of 2 quarters · filed 2022-03-11 | $14.34M derived: sum of 3 quarters · filed 2022-03-11 | $19.92M 10-K · filed 2022-03-11 | ||||
| 2020-09-30 | $4.59M 10-Q · filed 2021-11-05 | $8.87M derived: sum of 2 quarters · filed 2021-11-05 | $14.45M 10-Q · filed 2021-11-05 | $20.34M derived: sum of 4 quarters · filed 2021-11-05 | ||||
| 2020-06-30 | $4.28M 10-Q · filed 2021-08-06 | $9.86M 10-Q · filed 2021-08-06 | $15.75M derived: sum of 3 quarters · filed 2021-08-06 | $21.05M derived: sum of 4 quarters · filed 2021-08-06 | ||||
| 2020-03-31 | $5.58M 10-Q · filed 2021-05-07 | $11.47M derived: sum of 2 quarters · filed 2021-05-07 | $16.77M derived: sum of 3 quarters · filed 2021-05-07 | $22.54M derived: sum of 4 quarters · filed 2021-05-07 | ||||
| 2019-12-31 | $5.89M derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-03-17 | $11.19M derived: sum of 2 quarters · filed 2021-03-17 | $16.96M derived: sum of 3 quarters · filed 2021-03-17 | $23.26M 10-K/A · filed 2021-03-17 | ||||
| 2019-09-30 | $5.29M 10-Q · filed 2020-11-06 | $11.06M derived: sum of 2 quarters · filed 2020-11-06 | $17.37M 10-Q · filed 2020-11-06 | $23.84M derived: sum of 4 quarters · filed 2020-11-06 | ||||
| 2019-06-30 | $5.77M 10-Q · filed 2020-08-10 | $12.08M 10-Q · filed 2020-08-10 | $18.54M derived: sum of 3 quarters · filed 2020-08-10 | $24.56M derived: sum of 4 quarters · filed 2020-08-10 | ||||
| 2019-03-31 | $6.31M 10-Q · filed 2020-05-08 | $12.77M derived: sum of 2 quarters · filed 2020-05-08 | $18.79M derived: sum of 3 quarters · filed 2020-05-08 | $25.10M derived: sum of 4 quarters · filed 2020-05-08 | ||||
| 2018-12-31 | $6.47M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $12.49M derived: sum of 2 quarters · filed 2020-03-16 | $18.80M derived: sum of 3 quarters · filed 2020-03-16 | $24.44M 10-K · filed 2020-03-16 | ||||
| 2018-09-30 | $6.02M 10-Q · filed 2019-11-08 | $12.33M derived: sum of 2 quarters · filed 2019-11-08 | $17.98M 10-Q · filed 2019-11-08 | $22.39M derived: sum of 4 quarters · filed 2019-11-08 | ||||
| 2018-06-30 | $6.31M 10-Q · filed 2019-08-08 | $11.96M 10-Q · filed 2019-08-08 | $16.37M derived: sum of 3 quarters · filed 2019-08-08 | $20.01M derived: sum of 4 quarters · filed 2019-08-08 | ||||
| 2018-03-31 | $5.65M 10-Q · filed 2019-05-08 | $10.06M derived: sum of 2 quarters · filed 2019-05-08 | $13.70M derived: sum of 3 quarters · filed 2019-05-08 | $17.25M derived: sum of 4 quarters · filed 2019-05-08 | ||||
| 2017-12-31 | $4.42M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $8.05M derived: sum of 2 quarters · filed 2019-03-18 | $11.60M derived: sum of 3 quarters · filed 2019-03-18 | $15.08M 10-K · filed 2019-03-18 | $21.04M 10-K · filed 2018-03-16 | |||
| 2017-09-30 | $3.63M 10-Q · filed 2018-11-01 | $5.08M 10-Q · filed 2017-11-02 | $7.18M derived: sum of 2 quarters · filed 2018-11-01 | $10.66M 10-Q · filed 2018-11-01 | $15.11M 10-Q · filed 2017-11-02 | $15.96M derived: sum of 4 quarters · filed 2018-11-01 | ||
| 2017-06-30 | $3.55M 10-Q · filed 2018-08-02 | $4.98M 10-Q · filed 2017-08-03 | $7.03M 10-Q · filed 2018-08-02 | $10.03M 10-Q · filed 2017-08-03 | $12.32M derived: sum of 3 quarters · filed 2018-08-02 | $17.33M derived: sum of 4 quarters · filed 2018-08-02 | ||
| 2017-03-31 | $3.48M 10-Q · filed 2018-05-10 | $5.05M 10-Q · filed 2017-05-08 | $8.77M derived: sum of 2 quarters · filed 2018-05-10 | $13.78M derived: sum of 3 quarters · filed 2018-05-10 | $18.86M derived: sum of 4 quarters · filed 2018-05-10 | |||
| 2016-12-31 | $5.29M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $10.30M derived: sum of 2 quarters · filed 2018-03-16 | $15.38M derived: sum of 3 quarters · filed 2018-03-16 | $20.49M 10-K · filed 2018-03-16 | ||||
| 2016-09-30 | $5.01M 10-Q · filed 2017-11-02 | $10.09M derived: sum of 2 quarters · filed 2017-11-02 | $15.19M 10-Q · filed 2017-11-02 | $20.42M derived: sum of 4 quarters · filed 2018-03-16 | ||||
| 2016-06-30 | $5.09M 10-Q · filed 2017-08-03 | $10.19M 10-Q · filed 2017-08-03 | $15.41M derived: sum of 3 quarters · filed 2018-03-16 | $20.44M derived: sum of 4 quarters · filed 2018-03-16 | ||||
| 2016-03-31 | $5.10M 10-Q · filed 2017-05-08 | $10.32M derived: sum of 2 quarters · filed 2018-03-16 | $15.35M derived: sum of 3 quarters · filed 2018-03-16 | $20.48M derived: sum of 4 quarters · filed 2018-03-16 | ||||
| 2015-12-31 | $5.22M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $10.25M derived: sum of 2 quarters · filed 2018-03-16 | $15.38M derived: sum of 3 quarters · filed 2018-03-16 | $20.58M 10-K · filed 2018-03-16 | ||||
| 2015-09-30 | $5.03M 10-Q · filed 2016-11-03 | $10.16M derived: sum of 2 quarters · filed 2016-11-03 | $15.36M 10-Q · filed 2016-11-03 | $20.48M derived: sum of 4 quarters · filed 2017-03-17 | ||||
| 2015-06-30 | $5.13M 10-Q · filed 2016-08-04 | $10.33M 10-Q · filed 2016-08-04 | $15.45M derived: sum of 3 quarters · filed 2017-03-17 | $19.56M derived: sum of 4 quarters · filed 2017-03-17 | ||||
| 2015-03-31 | $5.20M 10-Q · filed 2016-05-16 | $10.32M derived: sum of 2 quarters · filed 2017-03-17 | $14.44M derived: sum of 3 quarters · filed 2017-03-17 | $18.99M derived: sum of 4 quarters · filed 2017-03-17 | ||||
| 2014-12-31 | $5.12M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-17 | $9.24M derived: sum of 2 quarters · filed 2017-03-17 | $13.79M derived: sum of 3 quarters · filed 2017-03-17 | $18.23M 10-K · filed 2017-03-17 | ||||
| 2014-09-30 | $4.11M 10-Q · filed 2015-11-05 | $8.67M derived: sum of 2 quarters · filed 2015-11-05 | $13.10M 10-Q · filed 2015-11-05 | $17.33M derived: sum of 4 quarters · filed 2016-04-29 | ||||
| 2014-06-30 | $4.56M 10-Q · filed 2015-08-06 | $8.99M 10-Q · filed 2015-08-06 | $13.21M derived: sum of 3 quarters · filed 2016-04-29 | $17.39M derived: sum of 4 quarters · filed 2016-04-29 | ||||
| 2014-03-31 | $4.43M 10-Q · filed 2015-05-07 | $8.66M derived: sum of 2 quarters · filed 2016-04-29 | $12.83M derived: sum of 3 quarters · filed 2016-04-29 | $17.22M derived: sum of 4 quarters · filed 2016-04-29 | ||||
| 2013-12-31 | $4.22M derived: 10-K 12 month − 10-Q 9 month · filed 2016-04-29 | $8.40M derived: sum of 2 quarters · filed 2016-04-29 | $12.79M derived: sum of 3 quarters · filed 2016-04-29 | $17.33M 10-K · filed 2016-04-29 | ||||
| 2013-09-30 | $4.17M 10-Q · filed 2014-11-06 | $4.41M 10-Q · filed 2013-11-08 | $8.57M derived: sum of 2 quarters · filed 2014-11-06 | $13.11M 10-Q · filed 2014-11-06 | $13.79M 10-Q · filed 2013-11-08 | $17.21M derived: sum of 4 quarters · filed 2015-03-12 | ||
| 2013-06-30 | $4.39M 10-Q · filed 2014-08-07 | $4.62M 10-Q · filed 2013-08-09 | $8.93M 10-Q · filed 2014-08-07 | $9.38M 10-Q · filed 2013-08-09 | $13.04M derived: sum of 3 quarters · filed 2015-03-12 | $17.71M derived: sum of 4 quarters · filed 2015-03-12 | ||
| 2013-03-31 | $4.54M 10-Q · filed 2014-05-08 | $4.75M 10-Q · filed 2013-05-10 | $8.64M derived: sum of 2 quarters · filed 2015-03-12 | $13.31M derived: sum of 3 quarters · filed 2015-03-12 | $18.06M derived: sum of 4 quarters · filed 2015-03-12 | |||
| 2012-12-31 | $4.11M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $8.78M derived: sum of 2 quarters · filed 2015-03-12 | $13.52M derived: sum of 3 quarters · filed 2015-03-12 | $18.29M 10-K · filed 2015-03-12 | $19.17M 10-K · filed 2013-03-18 | |||
| 2012-09-30 | $4.67M 10-Q · filed 2013-11-08 | $9.41M derived: sum of 2 quarters · filed 2013-11-08 | $14.18M 10-Q · filed 2013-11-08 | $18.28M derived: sum of 4 quarters · filed 2014-03-14 | ||||
| 2012-06-30 | $4.74M 10-Q · filed 2013-08-09 | $9.51M 10-Q · filed 2013-08-09 | $13.61M derived: sum of 3 quarters · filed 2014-03-14 | $17.97M derived: sum of 4 quarters · filed 2014-03-14 | ||||
| 2012-03-31 | $4.77M 10-Q · filed 2013-05-10 | $8.87M derived: sum of 2 quarters · filed 2014-03-14 | $13.23M derived: sum of 3 quarters · filed 2014-03-14 | $17.50M derived: sum of 4 quarters · filed 2014-03-14 | ||||
| 2011-12-31 | $4.10M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | $8.46M derived: sum of 2 quarters · filed 2014-03-14 | $12.73M derived: sum of 3 quarters · filed 2014-03-14 | $16.91M 10-K · filed 2014-03-14 | $17.47M 10-K · filed 2012-03-15 | |||
| 2011-09-30 | $4.36M 10-Q · filed 2012-11-08 | $8.63M derived: sum of 2 quarters · filed 2012-11-08 | $12.81M 10-Q · filed 2012-11-08 | $17.09M derived: sum of 4 quarters · filed 2013-03-18 | ||||
| 2011-06-30 | $4.27M 10-Q · filed 2012-08-09 | $8.45M 10-Q · filed 2012-08-09 | $12.73M derived: sum of 3 quarters · filed 2013-03-18 | $16.83M derived: sum of 4 quarters · filed 2013-03-18 | ||||
| 2011-03-31 | $4.18M 10-Q · filed 2012-05-10 | $8.46M derived: sum of 2 quarters · filed 2013-03-18 | $12.56M derived: sum of 3 quarters · filed 2013-03-18 | $16.75M derived: sum of 4 quarters · filed 2013-03-18 | ||||
| 2010-12-31 | $4.28M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $8.38M derived: sum of 2 quarters · filed 2013-03-18 | $12.58M derived: sum of 3 quarters · filed 2013-03-18 | $16.38M 10-K · filed 2013-03-18 | ||||
| 2010-09-30 | $4.10M 10-Q · filed 2011-11-09 | $8.29M derived: sum of 2 quarters · filed 2011-11-09 | $12.10M 10-Q · filed 2011-11-09 | |||||
| 2010-06-30 | $4.19M 10-Q · filed 2011-08-09 | $8.00M 10-Q · filed 2011-08-09 | ||||||
| 2009-12-31 | $11.76M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |